Smith Group Asset Management’s Regenxbio RGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-40
| Closed | -$2K | – | 391 |
|
|
2021
Q2 | $2K | Hold |
40
| – | – | ﹤0.01% | 360 |
|
|
2021
Q1 | $1K | Sell |
40
-1,100
| -96% | -$27.5K | ﹤0.01% | 326 |
|
|
2020
Q4 | $52K | Hold |
1,140
| – | – | ﹤0.01% | 217 |
|
|
2020
Q3 | $31K | Hold |
1,140
| – | – | ﹤0.01% | 224 |
|
|
2020
Q2 | $42K | Sell |
1,140
-20
| -2% | -$737 | ﹤0.01% | 209 |
|
|
2020
Q1 | $38K | Hold |
1,160
| – | – | ﹤0.01% | 256 |
|
|
2019
Q4 | $48K | Hold |
1,160
| – | – | ﹤0.01% | 281 |
|
|
2019
Q3 | $41K | Buy |
1,160
+420
| +57% | +$14.8K | ﹤0.01% | 292 |
|
|
2019
Q2 | $38K | Hold |
740
| – | – | ﹤0.01% | 291 |
|
|
2019
Q1 | $42K | Sell |
740
-2,800
| -79% | -$159K | ﹤0.01% | 310 |
|
|
2018
Q4 | $149K | Sell |
3,540
-100
| -3% | -$4.21K | 0.01% | 264 |
|
|
2018
Q3 | $275K | Buy |
+3,640
| New | +$275K | 0.01% | 232 |
|